NUCLEOLIN and neoplasm: In vitro experiments showed preferential uptake and cytotoxicity in nucleolin-positive cancer cells (e.g., MCF-7 cells), while in vivo studies in xenograft mouse models demonstrated a significant reduction in tumor growth compared to free doxorubicin, with lower systemic toxicity [80].